Navigation Links
CBI Announces 13th Annual Patient Assistance and Access Programs
Date:1/9/2012

WOBURN, Mass., Jan. 9, 2012 /PRNewswire/ -- Advanstar|CBI recently announced the full agenda for their 13th Annual Patient Assistance and Access Programs. The Forum takes place March 6-7, 2012 in Baltimore, MD.

PAP's speaker faculty includes leading experts from Eli Lilly, Genentech, AstraZeneca, Shire Human Genetic Therapies and many more.

Patient Assistance Pavilion participant Needy Meds recently interviewed PAP's Senior Program Manager, Sharon Langan. During the interview, Langan delved into the details of the conference, including new speakers and highlights from the agenda, notably, a new Safety Net Resources Track, chaired by Needy Meds.

This Forum is the most robust and renowned meeting for executives engaged in pharmaceutical patient assistance and access programs. For more information on the conference or to view the entire agenda, please visit http://www.cbinet.com/pap.

About CBI:

CBI, a subsidiary of Advanstar, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit http://www.cbinet.com.

For additional information or media inquiries, please contact Kristina Weljkovic, Marketing Manager, at 339-298-2285.

 

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
2. diaDexus, Inc. Pre-Announces 2011 Q4, YE Revenue and 2012 Guidance
3. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
4. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
5. Sutro Announces Newly Formed Scientific Advisory Board
6. AnaptysBio Announces New Strategic Antibody Discovery
7. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
8. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
9. AtheroNova Announces a New Board Member
10. RSB Spine, LLC Announces 2011 Revenue Growth
11. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... A ... in Hong Kong. , Nerium International is proud to introduce its Age-Defying Night ... Cream, NeriumAD™ Formula to consumers across Hong Kong. The luxury skincare products contain ...
(Date:2/17/2017)... Feb. 17, 2017  If only one in ... a mutation-conferring resistance to chemotherapy, thousands of cancer ... has focused on finding these mutations in ever-smaller ... circulating tumor DNA in blood — to guide ... Unfortunately, however, detecting these genetic anomalies ...
(Date:2/16/2017)... ... February 16, 2017 , ... Avomeen & MichBio will ... event will be held at Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, Michigan ... organization. They provide an opportunity to interact with peers, make new connections and talk ...
(Date:2/16/2017)... Feb. 16, 2017  ArmaGen, Inc., a privately ... to treat severe neurological disorders, today reported preliminary ... AGT-181, the company,s investigational therapy for the treatment ... mucopolysaccharidosis type I, or MPS I). The initial ... study, presented today at the 13 th ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):